Azzad Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $864K | Buy |
+2,651
| New | +$864K | 0.09% | 240 |
|
|
2023
Q3 | – | Sell |
-2,725
| Closed | -$518K | – | 303 |
|
|
2023
Q2 | $518K | Buy |
2,725
+11
| +0.4% | +$2.09K | 0.07% | 271 |
|
|
2023
Q1 | $544K | Buy |
2,714
+19
| +0.7% | +$3.81K | 0.08% | 265 |
|
|
2022
Q4 | $641K | Buy |
2,695
+24
| +0.9% | +$5.7K | 0.1% | 237 |
|
|
2022
Q3 | $535K | Buy |
2,671
+5
| +0.2% | +$1K | 0.05% | 336 |
|
|
2022
Q2 | $389K | Buy |
2,666
+62
| +2% | +$9.04K | 0.04% | 354 |
|
|
2022
Q1 | $425K | Sell |
2,604
-83
| -3% | -$13.6K | 0.06% | 280 |
|
|
2021
Q4 | $456K | Buy |
+2,687
| New | +$456K | 0.06% | 295 |
|